{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:41:53Z","timestamp":1789875713399,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013891","name":"Parkinson Vereniging","doi-asserted-by":"crossref","award":["2013-R02"],"award-info":[{"award-number":["2013-R02"]}],"id":[{"id":"10.13039\/501100013891","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BPRC and Neuroscience Campus Amsterdam"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.neuroscience.2015.09.065","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T15:00:46Z","timestamp":1444748446000},"page":"247-259","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage"],"prefix":"10.1016","volume":"312","author":[{"given":"S.K.","family":"Franke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"van Kesteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.M.","family":"Wubben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Paliukhovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"van der Schors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"van Nierop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.H.C.H.M.","family":"Philippens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2015.09.065_b0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fncir.2013.00152","article-title":"Dopamine signaling in reward-related behaviors","volume":"7","author":"Baik","year":"2013","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-2236(03)00038-9","article-title":"Presymptomatic compensation in Parkinson\u2019s disease is not dopamine-mediated","volume":"26","author":"Bezard","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0025","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0030","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1021\/ac502767y","article-title":"High sensitivity combined with extended structural coverage of labile compounds via nanoelectrospray ionization at subambient pressures","volume":"86","author":"Cox","year":"2014","journal-title":"Anal Chem"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0306-4522(02)00214-2","article-title":"Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets","volume":"114","author":"Dass","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson\u2019s disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0050","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1007\/s00415-014-7477-6","article-title":"Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD)","volume":"261","author":"De Rosa","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneumeth.2004.08.004","article-title":"Evaluation of animal models of Parkinson\u2019s disease for neuroprotective strategies","volume":"139","author":"Emborg","year":"2004","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0065","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2014-310256","article-title":"What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies","author":"Erro","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.brainresbull.2005.08.005","article-title":"Marmoset monkey models of Parkinson\u2019s disease: which model, when and why?","volume":"68","author":"Eslamboli","year":"2005","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0075","series-title":"Discovering Statistics using IBM SPSS Statistics","author":"Field","year":"2013"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0080","doi-asserted-by":"crossref","first-page":"e86240","DOI":"10.1371\/journal.pone.0086240","article-title":"Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates","volume":"9","author":"Fifel","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2015.09.065_b9000","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2174\/092986707781745550","article-title":"Noradrenaline in Parkinson\u2019s disease: from disease progression to current therapeutics","volume":"14","author":"Fornai","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01271546","article-title":"Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity","volume":"101","author":"Gnanalingham","year":"1995","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(95)00086-Z","article-title":"Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset","volume":"277","author":"Gnanalingham","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cne.10165","article-title":"Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei","volume":"445","author":"Hardman","year":"2002","journal-title":"J Comp Neurol"},{"issue":"Suppl. 4","key":"10.1016\/j.neuroscience.2015.09.065_b0100","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1353-8020(09)70829-6","article-title":"From the MPTP-treated primate to the treatment of motor complications in Parkinson\u2019s disease","volume":"15","author":"Jenner","year":"2009","journal-title":"Parkinson Relat Disord"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s002210000370","article-title":"Antiparkinsonian and neuroprotective effects of modafinil in the MPTP-treated common marmoset","volume":"133","author":"Jenner","year":"2000","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/RNN-110222","article-title":"Modeling early Parkinson\u2019s disease pathology with chronic low dose MPTP treatment","volume":"31","author":"Korecka","year":"2013","journal-title":"Restorat Neurol Neurosci"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11011-010-9195-9","article-title":"Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson\u2019s disease","volume":"25","author":"Kuroiwa","year":"2010","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0120","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fpsyt.2010.00128","article-title":"Biopsable neural tissues: toward new biomarkers for Parkinson\u2019s disease?","volume":"1","author":"Lebouvier","year":"2010","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0130","first-page":"1014","article-title":"Newton\u2014Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data","volume":"83","author":"Lindstrom","year":"1988","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0135","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/brain\/awm208","article-title":"A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery","volume":"130","author":"Mounayar","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.09.065_b9005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1460-9568.2009.06806.x","article-title":"Cortical serotonin and norepinephrine denervation in parkinsonism: Preferential loss of the beaded serotonin innervation","volume":"30","author":"Nayyar","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0140","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0091-3057(97)00552-2","article-title":"Effects of acute or prolonged administration of cabergoline on parkinsonism induced by MPTP in common marmosets","volume":"59","author":"Nomoto","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0150","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.etp.2012.09.001","article-title":"Toxicity of MPTP on neurotransmission in three mouse models of Parkinson\u2019s disease","volume":"65","author":"Pain","year":"2013","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy. 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0160","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbadis.2008.10.003","article-title":"Imaging neurodegeneration in Parkinson\u2019s disease","volume":"1792","author":"Pavese","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3758\/BF03200799","article-title":"Behavioral test systems in marmoset monkeys","volume":"32","author":"Philippens","year":"2000","journal-title":"Behav Res Methods Instrum Comput"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0170","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/WNR.0b013e3283360ba8","article-title":"Neurofeedback training on sensorimotor rhythm in marmoset monkeys","volume":"21","author":"Philippens","year":"2010","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s11481-013-9450-z","article-title":"Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model","volume":"8","author":"Philippens","year":"2013","journal-title":"J Neuroimmun Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b9015","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0022-3565(25)13093-0","article-title":"Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter","volume":"277","author":"Pifl","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2015.09.065_b9010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jnc.12162","article-title":"Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of Parkinsonism","volume":"125","author":"Pifl","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00140873","article-title":"Unconstrained parameterizations for variance\u2013covariance matrices","volume":"6","author":"Pinheiro","year":"1996","journal-title":"Stat Comput"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0185","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2015.09.065_b9020","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02785.x","article-title":"Reduced MPTP toxicity in noradrenaline transporter knockout mice","volume":"91","author":"Rommelfanger","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0190","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/0006-2952(89)90572-8","article-title":"Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets","volume":"38","author":"Rose","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3940(91)90171-O","article-title":"Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson\u2019s disease?","volume":"123","author":"Russ","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0200","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"Saeed","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0205","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2522\/ptj.20110472","article-title":"Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial","volume":"92","author":"Schenkman","year":"2012","journal-title":"Phys Ther"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0210","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","article-title":"Neurochemical findings in the MPTP model of Parkinson\u2019s disease","volume":"108","author":"Schmidt","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0215","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/biom5031467","article-title":"Is cell death primary or secondary in the pathophysiology of idiopathic Parkinson\u2019s disease?","volume":"5","author":"Schulz-Schaeffer","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson\u2019s disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson\u2019s disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/jnnp.68.3.313","article-title":"Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism","volume":"68","author":"Snow","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0235","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jnnp.61.6.645","article-title":"Disordered axial movement in Parkinson\u2019s disease","volume":"61","author":"Steiger","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0240","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","article-title":"Parkinson disease subtypes","volume":"71","author":"Thenganatt","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0245","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0250","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00008877-200609000-00011","article-title":"Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects","volume":"17","author":"van Vliet","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0255","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/pr201203m","article-title":"Synaptic proteome changes in a DNA repair deficient ercc1 mouse model of accelerated aging","volume":"11","author":"Vegh","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0260","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.5665\/SLEEP.1174","article-title":"REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease","volume":"34","author":"Verhave","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0265","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbr.2009.01.022","article-title":"Two new test methods to quantify motor deficits in a marmoset model for Parkinson\u2019s disease","volume":"200","author":"Verhave","year":"2009","journal-title":"Behav Brain Res"},{"issue":"Part 2","key":"10.1016\/j.neuroscience.2015.09.065_b0270","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neuroimage.2014.07.059","article-title":"Increased DAT binding in the early stage of the dopaminergic lesion: A longitudinal [11C]PE2I binding study in the MPTP-monkey","volume":"102","author":"Vezoli","year":"2014","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0275","doi-asserted-by":"crossref","first-page":"e23952","DOI":"10.1371\/journal.pone.0023952","article-title":"Early presymptomatic and long-term changes of rest activity cycles and cognitive behavior in a MPTP-monkey model of Parkinson\u2019s disease","volume":"6","author":"Vezoli","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0280","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0306-4522(87)90178-3","article-title":"An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset","volume":"23","author":"Waters","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2015.09.065_b9025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroimage.2014.01.060","article-title":"Permutation inference for the general linear model","volume":"92","author":"Winkler","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0285","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0091-3057(95)00006-I","article-title":"Effects of low doses of cholinesterase inhibitors on behavioral performance of robot-tested marmosets","volume":"51","author":"Wolthuis","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2015.09.065_b0295","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0091-3057(94)90291-7","article-title":"A simple automated test to measure exploratory and motor activity of marmosets","volume":"47","author":"Wolthuis","year":"1994","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215008921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215008921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:45:55Z","timestamp":1748652355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452215008921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":65,"alternative-id":["S0306452215008921"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2015.09.065","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}